MSL DAILY PHARMA NEWS - US approves Bavencio for bladder cancer #Bladdercancer #Bavencio #EMDserono #Pfizer “EMD Serono, the biopharmaceutical business of Merck KGaA, and Pfizer today announced that the US Food and Drug Administration (FDA) has expanded use of Bavencio (avelumab) to include maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy.” Free webinar on “how to become an MSL” https://lnkd.in/gFYBJ2G Or click on our profile. Click below to read further, like and share it and follow us to learn more. Our Medical Science Liaison testimonials: Http://https://lnkd.in/eEfHu4c #MSL #FSTP #MSLcert #medicalscienceliaison #Pharmacist #PHD #postdoc https://lnkd.in/g78ZxgD https://www.instagram.com/p/CCHP-eejJFv/?igshid=1734q5rr26hjh
